Active ingredient
Carfilzomib
3 finished FDA listings contain Carfilzomib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CARFILZOMIB
- Dosage forms
- Injection, Powder, Lyophilized, For Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 1
- Strengths listed
- 10 mg/5ml · 30 mg/15ml · 60 mg/30ml
- Brand names in FDA listings
- Kyprolis
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1302966
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 202714 | ONYX PHARMS AMGEN | 2012-07-20 | 3 |
Official labeling on DailyMed
- KYPROLIS (CARFILZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ONYX PHARMACEUTICALS, INC.] · version 59 · 2025-06-26
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.